These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 11464282)

  • 1. A repetitive element containing a critical tyrosine residue is required for transcriptional activation by the EWS/ATF1 oncogene.
    Feng L; Lee KA
    Oncogene; 2001 Jul; 20(31):4161-8. PubMed ID: 11464282
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The EWS/ATF1 fusion protein contains a dispersed activation domain that functions directly.
    Pan S; Ming KY; Dunn TA; Li KK; Lee KA
    Oncogene; 1998 Mar; 16(12):1625-31. PubMed ID: 9569031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An hsRPB4/7-dependent yeast assay for trans-activation by the EWS oncogene.
    Zhou H; Lee KA
    Oncogene; 2001 Mar; 20(12):1519-24. PubMed ID: 11313895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple aromatic side chains within a disordered structure are critical for transcription and transforming activity of EWS family oncoproteins.
    Ng KP; Potikyan G; Savene RO; Denny CT; Uversky VN; Lee KA
    Proc Natl Acad Sci U S A; 2007 Jan; 104(2):479-84. PubMed ID: 17202261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of the EWS oncogene transcriptional activation domain.
    Ng KP; Li KK; Lee KA
    Biochemistry; 2009 Apr; 48(13):2849-57. PubMed ID: 19290668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMSP tumor cells expressing the EWS/ATF1 oncogene do not support cAMP-inducible transcription.
    Li KK; Lee KA
    Oncogene; 1998 Mar; 16(10):1325-31. PubMed ID: 9546434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Promoters containing ATF-binding sites are de-regulated in cells that express the EWS/ATF1 oncogene.
    Brown AD; Lopez-Terrada D; Denny C; Lee KA
    Oncogene; 1995 May; 10(9):1749-56. PubMed ID: 7753552
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptional activation by the Ewing's sarcoma (EWS) oncogene can be cis-repressed by the EWS RNA-binding domain.
    Li KK; Lee KA
    J Biol Chem; 2000 Jul; 275(30):23053-8. PubMed ID: 10767297
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification and characterization of the nuclear localization/retention signal in the EWS proto-oncoprotein.
    Zakaryan RP; Gehring H
    J Mol Biol; 2006 Oct; 363(1):27-38. PubMed ID: 16965792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EWS-ATF-1 chimeric protein in soft tissue clear cell sarcoma associates with CREB-binding protein and interferes with p53-mediated trans-activation function.
    Fujimura Y; Siddique H; Lee L; Rao VN; Reddy ES
    Oncogene; 2001 Oct; 20(46):6653-9. PubMed ID: 11709699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA binding domains and nuclear localization signal of LEDGF: contribution of two helix-turn-helix (HTH)-like domains and a stretch of 58 amino acids of the N-terminal to the trans-activation potential of LEDGF.
    Singh DP; Kubo E; Takamura Y; Shinohara T; Kumar A; Chylack LT; Fatma N
    J Mol Biol; 2006 Jan; 355(3):379-94. PubMed ID: 16318853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RGG-boxes of the EWS oncoprotein repress a range of transcriptional activation domains.
    Alex D; Lee KA
    Nucleic Acids Res; 2005; 33(4):1323-31. PubMed ID: 15743974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The homeotic protein Six3 is a coactivator of the nuclear receptor NOR-1 and a corepressor of the fusion protein EWS/NOR-1 in human extraskeletal myxoid chondrosarcomas.
    Laflamme C; Filion C; Bridge JA; Ladanyi M; Goldring MB; Labelle Y
    Cancer Res; 2003 Jan; 63(2):449-54. PubMed ID: 12543801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The EWS-Oct-4 fusion gene encodes a transforming gene.
    Lee J; Kim JY; Kang IY; Kim HK; Han YM; Kim J
    Biochem J; 2007 Sep; 406(3):519-26. PubMed ID: 17564582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stimulation of Oct-4 activity by Ewing's sarcoma protein.
    Lee J; Rhee BK; Bae GY; Han YM; Kim J
    Stem Cells; 2005; 23(6):738-51. PubMed ID: 15917470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel EWS-WT1 gene fusion product in desmoplastic small round cell tumor is a potent transactivator of the insulin-like growth factor-I receptor (IGF-IR) gene.
    Werner H; Idelman G; Rubinstein M; Pattee P; Nagalla SR; Roberts CT
    Cancer Lett; 2007 Mar; 247(1):84-90. PubMed ID: 16730884
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Id2 gene is a novel target of transcriptional activation by EWS-ETS fusion proteins in Ewing family tumors.
    Nishimori H; Sasaki Y; Yoshida K; Irifune H; Zembutsu H; Tanaka T; Aoyama T; Hosaka T; Kawaguchi S; Wada T; Hata J; Toguchida J; Nakamura Y; Tokino T
    Oncogene; 2002 Nov; 21(54):8302-9. PubMed ID: 12447693
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tyrosine phosphorylation of adaptor protein 3BP2 induces T cell receptor-mediated activation of transcription factor.
    Qu X; Kawauchi-Kamata K; Miah SM; Hatani T; Yamamura H; Sada K
    Biochemistry; 2005 Mar; 44(10):3891-8. PubMed ID: 15751964
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the EWS/FLI-1 oncogene in murine primary bone-derived cells Results in EWS/FLI-1-dependent, ewing sarcoma-like tumors.
    Castillero-Trejo Y; Eliazer S; Xiang L; Richardson JA; Ilaria RL
    Cancer Res; 2005 Oct; 65(19):8698-705. PubMed ID: 16204038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular genetic characterization of the EWS/CHN and RBP56/CHN fusion genes in extraskeletal myxoid chondrosarcoma.
    Panagopoulos I; Mertens F; Isaksson M; Domanski HA; Brosjö O; Heim S; Bjerkehagen B; Sciot R; Dal Cin P; Fletcher JA; Fletcher CD; Mandahl N
    Genes Chromosomes Cancer; 2002 Dec; 35(4):340-52. PubMed ID: 12378528
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.